Brazikumab (Anti-IL-23)

Synonyms: AMG 139; MEDI2070

Brazikumab (Anti-IL-23) is a human IgG2 monoclonal antibody that selectively binds the p19 subunit of IL-23, with a KD of 0.138 nM for human IL-23. Brazikumab can be used for research on Crohn's disease. MW: 144.82 KD.

Brazikumab (Anti-IL-23)

Purity & Quality Control

Batch: A296501 Purity: 99% Protein concentration: 3.6mg/ml Endotoxin Level: <1EU/mg
99

Choose Selective Interleukins Inhibitors

Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Biological Activity

Description Brazikumab (Anti-IL-23) is a human IgG2 monoclonal antibody that selectively binds the p19 subunit of IL-23, with a KD of 0.138 nM for human IL-23. Brazikumab can be used for research on Crohn's disease. MW: 144.82 KD.

Product Details

CAS No. 1610353-18-8
Molecular Weight 144.82
Isotype Human IgG2SA
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Brazikumab (Anti-IL-23) | Brazikumab (Anti-IL-23) supplier | purchase Brazikumab (Anti-IL-23) | Brazikumab (Anti-IL-23) cost | Brazikumab (Anti-IL-23) manufacturer | order Brazikumab (Anti-IL-23) | Brazikumab (Anti-IL-23) distributor